Ir al menú de navegación principal Ir al contenido principal Ir al pie de página del sitio

Apnea central del sueño con patrón de respiración Cheynes-Stokes

Central sleep apnea with Cheyne-Stokes respiration



Abrir | Descargar


Sección
Reportes de casos

Cómo citar
Apnea central del sueño con patrón de respiración Cheynes-Stokes.
rev. colomb. neumol. [Internet]. 2017 Aug. 1 [cited 2024 Dec. 26];29(1):26-34. Disponible en: https://doi.org/10.30789/rcneumologia.v29.n1.2017.235

Dimensions
PlumX
Licencia

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Germán Díaz Santos
    Selene Guerrero

      Germán Díaz Santos,

      Epidemiólogo, Internista, Neumólogo, Somnólogo. Somnólogo y Director Médico, Clínica Somnomédica. Bogotá, Colombia.

      Selene Guerrero,

      Epidemióloga, Neumóloga, Fisióloga pulmonar. Instituto Nacional de Enfermedades Respiratorias. Ciudad de México, México.

      El síndrome de apnea central del sueño con patrón de Cheyne-Stokes es una patología prevalente en los pacientes con falla cardiaca. Ésta influencia la morbilidad y la mortalidad de la enfermedad, por lo cual se realizó una revisión narrativa de la literatura, enfocándonos en la epidemiología, fisiología y tratamiento de la apnea central del sueño con patrón de Cheyne-Stokes.

      Visitas del artículo 2176 | Visitas PDF 10103


      Descargas

      Los datos de descarga todavía no están disponibles.
      1. Panossian LA, Avidan AY. Review of sleep disorders. Med Clin North Am. 2009;93(2):407-25.
      2. The AASM Manual for the Scoring of Sleep and Associated Events. Summary of Updates in Version 2.2. July 1, 2015.
      3. The International Classification of Sleep Disorders, third edition (ICSD3), 1 published in 2014.
      4. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A.Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med. 1998;157(1):144-8.
      5. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest. 2005;128(3):1348-56.
      6. Johansson P, Alehagen U, Svanborg E, Dahlstrom U, Brostrom A. Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med. 2009;10(9):1005-11.
      7. Poletti R, Passino C, Giannoni A, Zyw L, et al. Risk factors and prognostic value of daytime Cheyne–Stokes respiration in chronic heart failure patients, Int J Cardiol. 2009;137:47–53.
      8. Flinta I, Ponikowski P. Relationship between central sleep apnea and Cheyne−Stokes respiration. Int J Cardiol. 2016;206:S8–S12.
      9. Luo Q, Zhang HL, Tao XC, Zhao ZH, Yang YJ, Liu ZH. Impact of untreated sleep apnea on prognosis of patients with congestive heart failure. Int J Cardiol. 2010;29:144(3):420-2.
      10. Pinna GD, Robbi E, Pizza F, Caporotondi A, et al. Sleepwake fluctuations and respiratory events during Cheyne–Stokes respiration in patients with heart failure. J Sleep Res.2014;23:349–59.
      11. Becker K, Byrd RP. Central sleep apnea syndromes. Disponible en: http://emedicine.medscape.com/article/304967overview#showall
      12. Yumino D, Bradley TD. Central sleep apnea and Cheyne–Stokes Respiration. Proc Am Thorac Soc. 2008;5:226–36.
      13. Francis DP, Willson K, Davies LC, et al. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation. 2000;102(18):2214–21.
      14. Sands SA, Edwards BA, Kee K, et al. Loop gain explains the resolution of Cheyne-Stokes respiration using inspired CO2 in patients with heart failure. Am J Respir Crit Care Med, 2012;185:A6697.
      15. Wellman AS, Jordan A, Malhotra et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170(11):1225–32.
      16. Brack T. Cheyne–Stokes respiration in patients with congestive heart failure. Swiss Med Wkly. 2003;133:605–10.
      17. Lorenzi-Filho G, Genta PR, Figueiredo AC, and Inoue D.Cheyne–Stokes respiration in patients with congestive heart failure: causes and consequences. Clinics. 2005;60:333–44.
      18. Costanzo MR, Khayat R, Ponikowski P, Augostini R, et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure, JACC. 2015;65(1):72–84.
      19. Calvin AD, Somers VK, Johnson BD, Scott ChG, Olson LJ. Left atrial size, chemosensitivity, and central sleep apnea in heart failure. Chest. 2014;146(1):96–103.
      20. Naughton M, Benard D, Tam A, Rutherford R, Bradley TD. Role of hyperventilation in the pathogenesis of central sleep apnea in patient with congestive heart failure. Am Rev Respir Dis. 1993;148(2):330–38.
      21. Oldenburg T, Bitter M, Wiemer et al. Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing. Sleep Med. 2009;10(7)726-30.
      22. Lanfranchi VK, Somers A, Braghiroli U, Corra et al. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk, Circulation. 2003;107:727–32.
      23. Cundrle Jr., Somers VK, Singh P, Johnson BD. Leptin deficiency promotes central sleep apnea in patients with heart failure. Chest. 2014;145(1):72–8.
      24. Sands SA, Owens RL. Congestive heart failure and central sleep apnea. Sleep Med Clin. 2016;11(1):127-42. doi:10.1016/j.jsmc.2015.10.003.
      25. Tamura A, Kawano Y, Kadota J. Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Circ J. 2009;73:295-98.
      26. Walsh JT, Andrews R, Evans A, Cowley AJ. Failure of ‘‘effective’’ treatment for heart failure to improve normal customary activity. Br Heart J. 1995;74:373-76.
      27. Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation.
      28. ;99(12):1574-9.
      29. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med. 2006;173:234-7.
      30. Andreas S, Reiter H, Luthje L, Delekat A, Grunewald RW,Hasenfuss G, et al. Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure. Circulation. 2004;110:2157-62.
      31. Lorenzi-Filho G, Rankin F, Bies I, Douglas BT. Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med. 1999;159:1490-8.
      32. Andreas S, Weidel K, Hagenah G, Heindl S. Treatment of Cheyne-Stokes respiration with nasal oxygen and carbon dioxide. Eur Respir J. 1998;12:414-9.
      33. Mebrate Y, Willson K, Manisty CH, Baruah R, Mayet J, Hughes AD, et al. Dynamic CO2 therapy in periodic breathing: a modeling study to determine optimal timing and dosage regimes. J Appl Physiol. 2009;107:696-706.
      34. Younes M. Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med. 2004;169:623-33.
      35. Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J. 2006;70:1-7.
      36. Gold AR, Bleecker ER, Smith PL. A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from lowflow oxygen. Am Rev Respir Dis. 1985;132:220-3.
      37. Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Resp Crit Care Med. 1995a;151:92–7.
      38. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-33.
      39. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61-6.
      40. Arzt M, Floras J, Logan A, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian continuous positive airway pressure of patients with central sleep apnea and heart failure trial (CANPAP). Circulation.2007;115:3173–80.
      41. Köhnlein T, Welte T, Tan LB, Elliott MW. Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Resp J. 2002;20:934-41; DOI: 10.1183/09031936.00.02622001.
      42. Randerath WJ, Galetke W, Kenter M, Richter K, Schafer T.Combined adaptive servo-ventilation and automatic positive airway pressure (anticyclic modulated ventilation) in co-existing obstructive and central sleep apnea syndrome and periodic breathing. Sleep Med. 2009;10:898–903.
      43. Teschler H, Dohring J, Wang Y, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med. 2001;164:614–9.
      44. Pepperell JC, Maskell NA, Jones DR, et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med. 2003;168(9):1109-14.
      45. Philippe C, Stoïca-Herman M, Drouot X, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period.Heart. 2006;92(3):337-42.
      46. Morgenthaler TI, Gay PC, Gordon N, Brown LK. Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep. 2007;30(4):468-75.
      47. Arzt M, Wensel R, Montalvan S, et al. Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest. 2008;134:61–6.
      48. Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, et al. JASV Investigators. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne–Stokes respiration. Circ Heart Fail. 2010;3(1):140–8.
      49. Pusalavidyasagar SS, Olson EJ, Gay PC, Morgenthaler TI. Treatment of complex sleep apnea syndrome: a retrospective comparative review. Sleep Med. 2006;7(6):474–9.
      50. Aurora RN, Bista SR, Casey KR, Chowdhuri S, Kristo DA, Mallea JM, et al. Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: “The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses”. J Clin Sleep Med. 2016;12(5):757-61. doi:10.5664/jcsm.5812.
      51. Ponikowski P, Javaheri S, Michalkiewicz D, Bart BA, Czar necka D, Jastrzebski M, et al. Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure. Eur Heart J. 2012;33(7):889-94. doi: 10.1093/eurheartj/ehr298. Epub 2011 Aug 19.
      52. Vermes E, Fonkoua H, Kirsch M, Damy T, Margarit L, Hillion ML, et al. () Resolution of sleep-disordered breathing with a biventricular assist device and recurrence after heart transplantation. J Clin Sleep Med. 2009;5:248-50.
      53. Mansfield DR, Solin P, Roebuck T, Bergin P, Kaye DM, Naughton MT. The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest. 2003;124(5):1675-81.
      Sistema OJS 3.4.0.7 - Metabiblioteca |